Research in the Wilson Lab focuses on the utility of radioactive and non-radioactive metal complexes in medicine for both therapeutic and diagnostic applications.
- Aohan Hu and Justin J. Wilson. “Advancing Chelation Strategies for Large Metal Ions for Nuclear Medicine Applications.” Acc. Chem. Res. 2022, 55, 904–915.
- Chilaluck C. Konkankit, Sierra C. Marker, Nicholas P. Bigham, Darren S. Dale, David B. Zax, Daniel R. Lorey II, and Justin J. Wilson. “Development and Implementation of Nuclear Chemistry Experiments at the Undergraduate Level.” J. Chem. Educ. 2021, 98, 3831–3840.
- Aohan Hu, Eduardo Aluicio-Sarduy, Victoria Brown, Samantha N. MacMillan, Kaelyn V. Becker, Todd E. Barnhart, Valery Radchenko, Caterina F. Ramogida, Jonathan W. Engle, and Justin J. Wilson. “Py-Macrodipa: A Janus Chelator Capable of Binding Medicinally Relevant Rare-Earth Radiometals of Disparate Sizes.” J. Am. Chem. Soc. 2021, 143, 10429–10440.
- Joshua J. Woods and Justin J. Wilson. “A Dinuclear Persulfide‐Bridged Ruthenium Compound is a Hypoxia‐Selective Hydrogen Sulfide (H2S) Donor.” Angew. Chem. Int. Ed. 2021, 60, 1588–1592.
- Sierra C. Marker, A. Paden King, Robert V. Swanda, Brett Vaughn, Eszter Boros, Shu-Bing Qian, and Justin J. Wilson. “Exploring Ovarian Cancer Cell Resistance to Rhenium Anticancer Complexes.” Angew. Chem. Int. Ed. 2020, 59, 13391–13400.
In the news
- Seed grants foster collaboration across Cornell campuses
- New Frontier Grants push boundaries in A&S research
- Three A&S professors honored with national chemistry awards
- Chemistry summer program = research + confidence
- Wilson wins grant to explore rare earth element opportunities
- Cornell Innovation Has Real-World Impact
- Expanding bone cancer therapy radium-223 for other cancers
- Foiling cancer aggression with nontoxic metals
- Chemistry professor honored with scholar award
- Meeting the power of chemistry
- Binding molecule could improve injected radiation therapy